AKT1 and colorectal carcinoma: Studies indicate that luteolin inhibits the activation of the PI3K/Akt signaling pathway, reducing the phosphorylation of Akt and mTOR, thus inhibiting CRC cell survival and enhancing the apoptotic effect [48].